---
title: "集齐12种细胞死亡方式，纯生信也能发13分"
date: 2024-03-07T00:41:59Z
draft: ["false"]
tags: [
  "fetched",
  "生信人"
]
categories: ["Acdemic"]
---
集齐12种细胞死亡方式，纯生信也能发13分 by 生信人
------
<div><p><span>哈喽，大家好，关于三阴性乳腺癌(TNBC)大家一定都熟悉，而TNBC患者术后进展和化疗耐药是导致治疗失败的主要原因。目前，对于术后TNBC患者的进展和药物敏感性缺乏理想的预测模型。小编今天给大家分享一篇发表在</span><strong><span>International Journal of Surgery（最新IF: 15.3）</span></strong><span>杂志上的文章，题目是:</span></p><p><span><br></span></p><p><span><strong><span>Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery</span></strong></span></p><p><span><br></span></p><p><span><strong><span>PCD个性化思路</span></strong></span></p><p><span><strong><span>扫码上车</span></strong></span></p><p><span><strong><span><img data-ratio="1" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBjCVqiajRoWIYOxmpy3E5ErKgzHEQEsOibBZqFciaDEMPEgUibFajs6ADXQ/640?wx_fmt=jpeg" data-type="jpeg" data-w="150" src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBjCVqiajRoWIYOxmpy3E5ErKgzHEQEsOibBZqFciaDEMPEgUibFajs6ADXQ/640?wx_fmt=jpeg"></span></strong></span></p><p><span><strong><span><br></span></strong></span></p><p><span><span>这篇文章分析了</span><span>12种程序性细胞死亡（Diverse programmed cell death，PCD）模式</span><span>（细胞凋亡、坏死性凋亡、焦亡、铁死亡、铜死亡、内源性细胞死亡、网状细胞死亡、依赖性细胞死亡、溶酶体依赖性细胞死亡、自噬依赖性细胞死亡、细胞内碱化死亡、氧自由基诱导死亡），利用机器学习算法建立了具有12个基因signature的细胞死亡指数（CDI），可以准确预测TNBC术后的临床预后和药物敏感性。</span></span></p><p><span><br></span></p><p><span>下面请大家和小编一起看看这篇文章的具体研究内容吧~</span></p><p><br></p><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><p><span><strong>一</strong></span></p></section></section></section><section><section powered-by="xiumi.us"><section><p><span><strong><span>研究背景</span></strong></span></p></section></section></section></section></section><ul><li><p><span>在乳腺癌的所有亚型中，三阴性乳腺癌(TNBC)最常见且最具侵袭性，占所有乳腺癌病例的15-20%。只有不到30%的转移性TNBC患者存活5年以上。由于其化疗耐药和预后差，治疗TNBC仍然是一项重大挑战，被认为是医疗领域的“巨大障碍”。</span></p><p><span><br></span></p></li><li><p><span>鉴于TNBC缺乏治疗方法，迫切需要探索新的靶点来改善TNBC的预后，有效的模型是使靶向治疗更加可行的必要条件。</span></p><p><span><br></span></p></li><li><p><span>几十年来，PCD已被证实在恶性肿瘤的发展和转移中起着根本性的作用。恶性肿瘤细胞如果不克服各种形式的细胞死亡就不能进一步发展。</span></p><p><span><br></span></p></li><li><p><span>关于PCD与TNBC之间关系的研究尚不全面，PCD在TNBC中的具体作用研究较少。</span></p></li></ul><p><span><br></span></p><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><p><span><strong>二</strong></span></p></section></section></section><section><section powered-by="xiumi.us"><section><p><span><strong><span>研究内容与结果</span></strong></span></p></section></section></section></section></section><p><span><strong><span>1、研究工作流程</span></strong></span></p><p><span>对于训练和验证队列，作者从TCGA中确定了1102例患者，从GSE58812中确定了107例患者，从METABRIC中确定了1992例患者，从GSE21653中确定了266例接受手术的患者。其中，来自TCGA的115例患者、来自GSE58812的107例患者、来自METABRIC的298例患者和来自GSE21653的85例患者符合纳入标准。对于单细胞RNA转录组数据集，作者从GSE75688中收集了5例患者，从GSE176078中收集了9例患者。本研究流程图如图1所示。</span></p><p><span><br></span></p><p><shape type="#_x0000_t75" filled="f"><imagedata title="image1"></imagedata></shape></p><p><img data-galleryid="" data-ratio="0.882091212458287" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBQXLPcn3TgUtk5ibUyXu2Wou1v0GGoANek0z1iamUBho1MwvhITyTmnqg/640?wx_fmt=png" data-type="png" data-w="899" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBQXLPcn3TgUtk5ibUyXu2Wou1v0GGoANek0z1iamUBho1MwvhITyTmnqg/640?wx_fmt=png"></p><p><span>图1. 三阴性乳腺癌(TNBC)术后患者不同细胞死亡模式综合分析流程图</span><br></p><p><br></p><p><span><strong><span>2、TNBC患者程序性细胞死亡基因的变异landscape</span></strong></span></p><p><span>(A) TNBC与正常组织之间的血小板相关DEGs热图。</span></p><p><span>(B) PCD相关DEGs的火山图(绿色:下调的DEGs;红色:上调的DEGs)。</span></p><p><span>(C) TCGA队列中PCD相关DEGs的位置、表达和相关性。</span></p><p><span>(D)基于DEGs的KEGG通路富集分析。</span></p><p><span>(E)基于DEGs的GO功能富集分析。</span></p><p><span>(F)TCGA队列中PCD相关基因的致癌位点。</span></p><p><span>(G)TCGA队列中PCD相关基因的CNV值。</span></p><p><span><br></span></p><p><img data-galleryid="" data-ratio="0.32407407407407407" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBP28Ix3gyZCSianpGLLYHeVWrBiblyd3Cgz4G8zy3tJDurdLMgbd2jr5g/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBP28Ix3gyZCSianpGLLYHeVWrBiblyd3Cgz4G8zy3tJDurdLMgbd2jr5g/640?wx_fmt=png"></p><p><img data-galleryid="" data-ratio="0.3675925925925926" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBErJJUCMnGq5ibf3FsEnb1pjnRMgEib3PLlH8jzuhF3IeQGFUcEwwyEicg/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBErJJUCMnGq5ibf3FsEnb1pjnRMgEib3PLlH8jzuhF3IeQGFUcEwwyEicg/640?wx_fmt=png"></p><p><img data-galleryid="" data-ratio="0.3314814814814815" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBJWg2kkjIwvzrsibuDefziaWF3ObzCraQxQ6jvG49nmY717aJG5zaeqoQ/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBJWg2kkjIwvzrsibuDefziaWF3ObzCraQxQ6jvG49nmY717aJG5zaeqoQ/640?wx_fmt=png"></p><p><img data-galleryid="" data-ratio="0.3175925925925926" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBdGgxmc2lmtq6IFa6ReFYf8nPd1E2WkXGkiao1Y6oicX6z6tbmmwOKxAA/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBdGgxmc2lmtq6IFa6ReFYf8nPd1E2WkXGkiao1Y6oicX6z6tbmmwOKxAA/640?wx_fmt=png"></p><p><span>图2. TNBC患者程序性细胞死亡基因的变异landscape</span></p><p><span><br></span></p><p><span><strong><span>3、TNBC患者预后基因signature的构建</span></strong></span></p><p><span>(A)通过机器学习方法选择12个模型基因。</span></p><p><span>(B)signature的交叉验证。</span></p><p><span>(C)CDI与不同TNBC分子亚型之间关系的小提琴图。</span></p><p><span>(D)CDI与生存状况、T、N、临床分期关系的小提琴图。</span></p><p><span>(E)12种模式基因与临床特征间关系热图。</span></p><p><span>(F)TCGA队列中两个CDI组之间top10富集生物学功能的Ridge plot展示。</span></p><p><span>(G)TCGA队列、GSE58812队列和METABRIC队列之间生物功能富集的Venn图。</span></p><p><span>(H)PCD相关基因与异生物质代谢的相关网络(红色为上调基因，绿色为下调基因，线的粗细和色深显示了相关性的强弱)</span></p><p><span><br></span></p><p><img data-galleryid="" data-ratio="0.3351851851851852" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBJbgyY7z11Yy4PTkhBibHshzsYXsqPqhLdD8bhahITeJ6GBEia5tNMicbQ/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBJbgyY7z11Yy4PTkhBibHshzsYXsqPqhLdD8bhahITeJ6GBEia5tNMicbQ/640?wx_fmt=png"></p><p><img data-galleryid="" data-ratio="0.2796296296296296" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rB46gn3l1v4libYtWR4DcIBS9FMOKZibFykR6x9zH53R2HTSbKuO8hpjdQ/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rB46gn3l1v4libYtWR4DcIBS9FMOKZibFykR6x9zH53R2HTSbKuO8hpjdQ/640?wx_fmt=png"></p><p><img data-galleryid="" data-ratio="0.4703703703703704" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBTr1AEXXsYFVbpia8VqCZej2E5DSqXu0n2xP4p7bagkmYHqJSMWu34dA/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBTr1AEXXsYFVbpia8VqCZej2E5DSqXu0n2xP4p7bagkmYHqJSMWu34dA/640?wx_fmt=png"></p><p><img data-galleryid="" data-ratio="0.3" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBKBrDkoBgseTib8aA9UDhmby3RmBic0UXOzgwVacRez4H6euVCryxJ6wg/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBKBrDkoBgseTib8aA9UDhmby3RmBic0UXOzgwVacRez4H6euVCryxJ6wg/640?wx_fmt=png"></p><p><span>图3. TNBC患者预后基因signature的构建</span></p><p><strong><span><br></span></strong></p><p><span><strong><span>4、基因特征预测模型的内部训练和外部验证</span></strong></span></p><p><span>(A) TCGA、GSE58812、METABRIC和GSE21653队列中根据生存状态和时间调整后的CDI分布。</span></p><p><span>(B) TCGA、GSE58812、METABRIC和GSE21653队列中基于CDI的主成分分析(PCA)图。</span></p><p><span>(C、D) TCGA、GSE58812、METABRIC、GSE21653和KM-plotter队列中低CDI组和高CDI组患者的总生存期、无病生存期和无复发生存期。</span></p><p><span><br></span></p><p><img data-galleryid="" data-ratio="0.34814814814814815" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBtVgtvhcNxA7O6fNZf27lr1mygBial1EA6Av8McyHnLNY4x3xWCcibsicg/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBtVgtvhcNxA7O6fNZf27lr1mygBial1EA6Av8McyHnLNY4x3xWCcibsicg/640?wx_fmt=png"></p><p><img data-galleryid="" data-ratio="0.38055555555555554" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rB3ic5tvzQ2FUhEeGxr7CicbESRPxibC9Z6CtIXNiaqQhuQkwic4aV9CjxHyA/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rB3ic5tvzQ2FUhEeGxr7CicbESRPxibC9Z6CtIXNiaqQhuQkwic4aV9CjxHyA/640?wx_fmt=png"></p><p><img data-galleryid="" data-ratio="0.2037037037037037" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBO02SVGeHF2woPII3xpVfxw4n7fkAl84bEd4QhMZgibGgiaxAxmM8by6Q/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBO02SVGeHF2woPII3xpVfxw4n7fkAl84bEd4QhMZgibGgiaxAxmM8by6Q/640?wx_fmt=png"></p><p><span>图4.基因特征预测模型的内部训练和外部验证</span></p><p><span><br></span></p><p><span><strong><span>5、程序性细胞死亡相关模型基因的无监督聚类</span></strong></span></p><p><span>(A)根据程序性细胞死亡模型基因谱，将TNBC患者分为两个分子簇（k=2）。</span></p><p><span>(B)经验累积分布函数图，显示每个k值(2~10)的共识分布。</span></p><p><span>(C)属于两种不同分子簇的TNBC患者预后的Kaplan-Meier分析。</span></p><p><span>(D)冲积图显示TNBC患者分子簇、生存状态和CDI组之间的相互关系。</span></p><p><span><br></span></p><p><img data-galleryid="" data-ratio="0.5175925925925926" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBsibYw8U4qicKHyYWaf4vMaeSYRlv8Zvh4UaULSkW9IgIbUC9YN4tfTwg/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBsibYw8U4qicKHyYWaf4vMaeSYRlv8Zvh4UaULSkW9IgIbUC9YN4tfTwg/640?wx_fmt=png"></p><p><img data-galleryid="" data-ratio="0.5175925925925926" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBJZh4wH19YLsAhAOicTvtndBSbtadsg3Yic11XjT3ibpwW96vKPNbfNEKA/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBJZh4wH19YLsAhAOicTvtndBSbtadsg3Yic11XjT3ibpwW96vKPNbfNEKA/640?wx_fmt=png"></p><p><span>图5.程序性细胞死亡相关模型基因的无监督聚类</span></p><p><br></p><p><span><strong><span>6、nomogram生存模型的建立与评估</span></strong></span></p><p><span>(A) TCGA队列中临床病理特征和CDI的单因素分析。</span></p><p><span>(B) TCGA队列中临床病理特征和CDI的多因素分析。</span></p><p><span>(C)建立nomogram来预测TNBC患者的预后。</span></p><p><span>(D)显示TCGA队列中2年、3年和5年总生存概率的校准图。</span></p><p><span>(E) nomogram预测2、3、5年总生存率的决策曲线分析(DCA)。</span></p><p><span>(F)基于nomogram评分对两个TNBC组进行Kaplan-Meier分析。</span></p><p><span>(G) TCGA、GSE58812、METABRIC和GSE21653队列中nomogram ROC分析。</span></p><p><span><br></span></p><p><img data-galleryid="" data-ratio="0.25092592592592594" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBb7FMvRKibPUFF8Q6TpkC1jeCAwGN8icY32YkELS032VoUoKc9sca3UZQ/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBb7FMvRKibPUFF8Q6TpkC1jeCAwGN8icY32YkELS032VoUoKc9sca3UZQ/640?wx_fmt=png"></p><p><img data-galleryid="" data-ratio="0.3351851851851852" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBZarSUniaYOyuSbZfaea1ZdiaV6Y8NvaGhsG7WDM7icuAv84F3Pf1V5icvw/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBZarSUniaYOyuSbZfaea1ZdiaV6Y8NvaGhsG7WDM7icuAv84F3Pf1V5icvw/640?wx_fmt=png"></p><p><img data-galleryid="" data-ratio="0.6046296296296296" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBURqicY7ib0X6hM4UG0viaia5ELU1vzcvMXKPZJMowx9f4DicpzqfhcfEhjw/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBURqicY7ib0X6hM4UG0viaia5ELU1vzcvMXKPZJMowx9f4DicpzqfhcfEhjw/640?wx_fmt=png"></p><p><span>图6. nomogram生存模型的建立与评估</span></p><p><span><br></span></p><p><span><strong><span>7、基于程序性细胞死亡特征的肿瘤微环境解析</span></strong></span></p><p><span>(A) TNBC患者免疫调节因子与CDI值之间的相关性柱状图。</span></p><p><span>(B)显示TCGA、GSE58812、METABRIC和GSE21653队列中M2/M1巨噬细胞比率与CDI值之间关系的箱线图和相关图。</span></p><p><span>(C)9例TNBC患者所有细胞亚型的t-SNE图可视化。</span></p><p><span>(D) CDI分布的t-SNE图可视化。</span></p><p><span>(E)每个TNBC患者细胞比例的条形图。</span></p><p><span>(F)不同细胞类型CDI值的小提琴图。</span></p><p><span>(G)模型基因在不同细胞亚型中的平均表达量和百分比的气泡图。</span></p><p><span><br></span></p><p><img data-galleryid="" data-ratio="0.2833333333333333" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rB4OGclibT91OdjdSsrJGUmOCQC0zSE8Et28ic17m2msqvyT7MfezRN7Ag/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rB4OGclibT91OdjdSsrJGUmOCQC0zSE8Et28ic17m2msqvyT7MfezRN7Ag/640?wx_fmt=png"></p><p><img data-galleryid="" data-ratio="0.49074074074074076" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBxyYicWvZialhcUqRYH2oMXMol4V1KzmXeOQ5cE7GEMT2yUJ1AsHu5l2g/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBxyYicWvZialhcUqRYH2oMXMol4V1KzmXeOQ5cE7GEMT2yUJ1AsHu5l2g/640?wx_fmt=png"></p><p><img data-galleryid="" data-ratio="0.524074074074074" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBo8qibgJ7esh8bPCJCqXoYSHeSxuicr9E80acvicQviaibHngO5uSlHaibsXw/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBo8qibgJ7esh8bPCJCqXoYSHeSxuicr9E80acvicQviaibHngO5uSlHaibsXw/640?wx_fmt=png"></p><p><span>图7. 基于程序性细胞死亡特征的肿瘤微环境解析</span></p><p><br></p><p><span><strong><span>8、signature在预测药物敏感性中的作用</span></strong></span></p><p><span>(A)药物敏感性、CDI和模型基因之间关系气泡图。</span></p><p><span>(B)高CDI组和低CDI组药物IC50比较箱线图，以及TCGA队列中IC50与CDI值的相关性。</span></p><p><span>(C)乳腺癌模型基因与经典治疗靶点的相关性。红线代表正相关，蓝线代表负相关。</span></p><p><span>(D)高CDI组和低CDI组TIDE评分比较的箱线图，以及TNBC患者TIDE评分与CDI值的相关性。</span></p><p><span><br></span></p><p><img data-galleryid="" data-ratio="0.3425925925925926" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBXN5m2o6Al5LicichT9hRQkQaaB3RO7lqT3NTWLROY0VV5pwCpDjQwy8g/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBXN5m2o6Al5LicichT9hRQkQaaB3RO7lqT3NTWLROY0VV5pwCpDjQwy8g/640?wx_fmt=png"></p><p><img data-galleryid="" data-ratio="0.5185185185185185" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBTlxF7SylXPk2BBXUGY9soTpoiaEKJsqiaR1ibvoupPW6RzxxfyVXa6w6w/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBTlxF7SylXPk2BBXUGY9soTpoiaEKJsqiaR1ibvoupPW6RzxxfyVXa6w6w/640?wx_fmt=png"></p><p><img data-galleryid="" data-ratio="0.48148148148148145" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rB61iaHOHenVmFxibbg18xwPlSGq5A2DjuoiczL6sTHPnwEBn4mb7f1M23A/640?wx_fmt=png" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVFPGsNnav4lI69YLkK17rB61iaHOHenVmFxibbg18xwPlSGq5A2DjuoiczL6sTHPnwEBn4mb7f1M23A/640?wx_fmt=png"></p><p><span>图8.signature在预测药物敏感性中的作用</span></p><p><span><br></span></p><p><span>以上就是这篇高分文章的全部内容，这项研究首次全面分析了12种不同的PCD模式，在TCGA队列中构建了一个包含12个PCD相关基因(ATP6V0D1、CDKN1A、PTPN2、MUL1、SERPINE1、LAMP3、RRP8、PINK1、PRKAA2、VDAC1、BCL2A1和MT1G)的signature，发现它可以预测TNBC患者的总体和无病生存期，并在四个外部队列(GSE58812、METABRIC、GSE21653和KM-plotter)中进一步验证了signature的预测能力。作者还构建了包含临床特征和CDI的nomogram，确定了CDI是否与免疫调节剂、肿瘤微环境和药物敏感性相关。</span></p><p><span><br></span></p><p><span><span>总之，这项研究提出的PCD相关基因标记是一种实用的预测术后TNBC患者预后的指标，对临床预后的评估具有显著意义。</span><span>对于肿瘤患者，PCD相关基因的重要性不言而喻，结合公共数据或者自测数据与公共数据联合分析各种癌型中PCD概况，绝对具有挖掘价值!</span><span>生信人已经为大家准备好了相关思路，趁热乎，感兴趣的小伙伴抓紧咨询吧！</span></span></p><p><span><br></span></p><p><span><strong><span>PCD个性化思路</span></strong></span></p><p><span><strong><span>扫码上车</span></strong></span></p><p><span><strong><span><img data-ratio="1" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBjCVqiajRoWIYOxmpy3E5ErKgzHEQEsOibBZqFciaDEMPEgUibFajs6ADXQ/640?wx_fmt=jpeg" data-type="jpeg" data-w="150" src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjVFPGsNnav4lI69YLkK17rBjCVqiajRoWIYOxmpy3E5ErKgzHEQEsOibBZqFciaDEMPEgUibFajs6ADXQ/640?wx_fmt=jpeg"></span></strong></span></p><p><br></p><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><svg viewbox="0 0 1 1"></svg></section></section></section><section><section powered-by="xiumi.us"><p><strong>往期热点 </strong><span><strong><span>（点击标题跳转）</span></strong></span></p></section></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>01</strong></p></section></section><section><a title="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214528&amp;idx=2&amp;sn=0b81200f628c17669485151ade52925d&amp;chksm=8b5f55afbc28dcb9c93ff31400a893604301943ddfb50d6c8406eb8737bb6d9f6a7fb5f57c71&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" formlinkparm='"https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214528&amp;idx=2&amp;sn=0b81200f628c17669485151ade52925d&amp;chksm=8b5f55afbc28dcb9c93ff31400a893604301943ddfb50d6c8406eb8737bb6d9f6a7fb5f57c71&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect"' href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214528&amp;idx=2&amp;sn=0b81200f628c17669485151ade52925d&amp;chksm=8b5f55afbc28dcb9c93ff31400a893604301943ddfb50d6c8406eb8737bb6d9f6a7fb5f57c71&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" target="_blank" rel="noopener noreferrer" powered-by="xiumi.us" data-linktype="2"><section><p><strong>线粒体质量控制</strong></p></section></a></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>02</strong></p></section></section><section><a title="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214712&amp;idx=1&amp;sn=09dd54fe9f077c3a25cfc3b7b40b339f&amp;chksm=8b5f5417bc28dd0158bffa8c928296428f31c897abba4b12daaeae05f655a47889dec37ff6ab&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" formlinkparm='"https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214712&amp;idx=1&amp;sn=09dd54fe9f077c3a25cfc3b7b40b339f&amp;chksm=8b5f5417bc28dd0158bffa8c928296428f31c897abba4b12daaeae05f655a47889dec37ff6ab&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect"' href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214712&amp;idx=1&amp;sn=09dd54fe9f077c3a25cfc3b7b40b339f&amp;chksm=8b5f5417bc28dd0158bffa8c928296428f31c897abba4b12daaeae05f655a47889dec37ff6ab&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" target="_blank" rel="noopener noreferrer" powered-by="xiumi.us" data-linktype="2"><section><p><strong>孟德尔随机化</strong></p></section></a></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>03</strong></p></section></section><section><a title="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651213782&amp;idx=1&amp;sn=6fab7af7962d65694a35e3f52abf39e4&amp;chksm=8b5f48b9bc28c1afbd0ec13b9eae9d8e08bf1a3c852d72e4c0c6420394fa362b1678d1a818ec&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" formlinkparm='"https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651213782&amp;idx=1&amp;sn=6fab7af7962d65694a35e3f52abf39e4&amp;chksm=8b5f48b9bc28c1afbd0ec13b9eae9d8e08bf1a3c852d72e4c0c6420394fa362b1678d1a818ec&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect"' href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651213782&amp;idx=1&amp;sn=6fab7af7962d65694a35e3f52abf39e4&amp;chksm=8b5f48b9bc28c1afbd0ec13b9eae9d8e08bf1a3c852d72e4c0c6420394fa362b1678d1a818ec&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" target="_blank" rel="noopener noreferrer" powered-by="xiumi.us" data-linktype="2"><section><p><strong>成纤维细胞（CAFs）</strong></p></section></a></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>04</strong></p></section></section><section><a title="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214743&amp;idx=1&amp;sn=e8ff475ef8015a9222db5381416578d8&amp;chksm=8b5f54f8bc28ddee1f61b4fd9c1e4ba11dec78ca41a462e6b0b2c493864a95859ba6cf6f55d6&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" formlinkparm='"https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214743&amp;idx=1&amp;sn=e8ff475ef8015a9222db5381416578d8&amp;chksm=8b5f54f8bc28ddee1f61b4fd9c1e4ba11dec78ca41a462e6b0b2c493864a95859ba6cf6f55d6&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect"' href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214743&amp;idx=1&amp;sn=e8ff475ef8015a9222db5381416578d8&amp;chksm=8b5f54f8bc28ddee1f61b4fd9c1e4ba11dec78ca41a462e6b0b2c493864a95859ba6cf6f55d6&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" target="_blank" rel="noopener noreferrer" powered-by="xiumi.us" data-linktype="2"><section><p><strong>单细胞空间转录组</strong></p></section></a></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>05</strong></p></section></section><section><a title="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651203828&amp;idx=1&amp;sn=c09dbafd10d170359061258913d3c7d6&amp;chksm=8b5f2f9bbc28a68de8996969b13f26c20c051fe30be2bfc409b3391e0764ac2d20bd09efcf2f&amp;scene=21#wechat_redirect" formlinkparm='"https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651203828&amp;idx=1&amp;sn=c09dbafd10d170359061258913d3c7d6&amp;chksm=8b5f2f9bbc28a68de8996969b13f26c20c051fe30be2bfc409b3391e0764ac2d20bd09efcf2f&amp;scene=21#wechat_redirect"' href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651203828&amp;idx=1&amp;sn=c09dbafd10d170359061258913d3c7d6&amp;chksm=8b5f2f9bbc28a68de8996969b13f26c20c051fe30be2bfc409b3391e0764ac2d20bd09efcf2f&amp;scene=21#wechat_redirect" target="_blank" rel="noopener noreferrer" powered-by="xiumi.us" data-linktype="2"><section><p><strong>肿瘤相关巨噬细胞（TAM）</strong></p></section></a></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>06</strong></p></section></section><section><a title="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651201615&amp;idx=1&amp;sn=154c456e092116f117e2dd478b05360b&amp;chksm=8b5f2720bc28ae36b5fe6679f26f02b4f4e5dbd40d131841bab2b5b2f750d9eb44755d762f0a&amp;scene=21#wechat_redirect" formlinkparm='"https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651201615&amp;idx=1&amp;sn=154c456e092116f117e2dd478b05360b&amp;chksm=8b5f2720bc28ae36b5fe6679f26f02b4f4e5dbd40d131841bab2b5b2f750d9eb44755d762f0a&amp;scene=21#wechat_redirect"' href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651201615&amp;idx=1&amp;sn=154c456e092116f117e2dd478b05360b&amp;chksm=8b5f2720bc28ae36b5fe6679f26f02b4f4e5dbd40d131841bab2b5b2f750d9eb44755d762f0a&amp;scene=21#wechat_redirect" target="_blank" rel="noopener noreferrer" powered-by="xiumi.us" data-linktype="2"><section><p><strong>细胞死亡</strong></p></section></a></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>07</strong></p></section></section><section><a title="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214658&amp;idx=1&amp;sn=3ac27a20520442e202f7b39463c53e3a&amp;chksm=8b5f542dbc28dd3b83bfad73ae4876771060da87292aa6f0b4eec06420dc35191f1034a504e6&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" formlinkparm='"https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214658&amp;idx=1&amp;sn=3ac27a20520442e202f7b39463c53e3a&amp;chksm=8b5f542dbc28dd3b83bfad73ae4876771060da87292aa6f0b4eec06420dc35191f1034a504e6&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect"' href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214658&amp;idx=1&amp;sn=3ac27a20520442e202f7b39463c53e3a&amp;chksm=8b5f542dbc28dd3b83bfad73ae4876771060da87292aa6f0b4eec06420dc35191f1034a504e6&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" target="_blank" rel="noopener noreferrer" powered-by="xiumi.us" data-linktype="2"><section><p><strong>耐药</strong></p></section></a></section></section></section></section><section powered-by="xiumi.us"><p><br></p></section><section powered-by="xiumi.us"><p><br></p></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><img data-ratio="1" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVBuSPMUjA8ErAYic9knJHe7EVuoAFRs4hc9q7xx8kyH3aCoicxSbZIicBzxa9CS5hYaVfFgCuf5sE6A/640?wx_fmt=png" data-type="png" data-w="350" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVBuSPMUjA8ErAYic9knJHe7EVuoAFRs4hc9q7xx8kyH3aCoicxSbZIicBzxa9CS5hYaVfFgCuf5sE6A/640?wx_fmt=png"></section></section><section powered-by="xiumi.us"><section><p><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651215446&amp;idx=1&amp;sn=9a9746271d4326550052399b06a692f6&amp;chksm=8b5f5139bc28d82f84eb58f8b2d13e521d0077363e2488cb90740795d78cb0b9d64d524f793a&amp;token=1604657443&amp;lang=zh_CN&amp;scene=21#wechat_redirect" target="_blank" data-linktype="2">课题设计</a> | 组学测序 |<a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651215446&amp;idx=2&amp;sn=738ca6454e16270173f9ed545cb4f3b3&amp;chksm=8b5f5139bc28d82ffd7122f3261ae30b6bdfe319373cd7185e8f030324eab7ff1f7cd43b7be3&amp;token=1604657443&amp;lang=zh_CN&amp;scene=21#wechat_redirect" target="_blank" data-linktype="2">生信分析</a></p><p>培训工具 | 热点互动 | 资源互换</p></section></section></section></section><section powered-by="xiumi.us"><p><br></p></section><section powered-by="xiumi.us"><p><span>图文排版｜CY</span></p><p>文章转载请联系 | 15510012760（微信）</p><p>广告商务合作 | 18501253903（微信）</p></section><section powered-by="xiumi.us"><p><br></p></section></section></section></section><p><span><strong><span></span></strong></span></p><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/ZdryruwRXqBgOQTayfFF4g",target="_blank" rel="noopener noreferrer">原文链接</a>
